Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWoodbois Regulatory News (WBI)

  • This share is currently suspended. It was suspended at a price of 0.03
  • There is currently no data for WBI

Additional Fundraising

2 Feb 2018 17:06

RNS Number : 8379D
Obtala Limited
02 February 2018
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014.

 

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF OBTALA LIMITED.

 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

 

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021)

 

 

2 February 2018

 

Obtala Limited

("Obtala" or the "Company") (AIM: OBT)

 

Additional Fundraising of at least £0.68m ($0.96m) via a Subscription, an Institutional Placing and Offer via PrimaryBid

 

Obtala Limited (AIM: OBT), the African focused agricultural and forestry company, is pleased to announce, further to the subscription to raise £4.5m (US$6.25m) (before expenses) announced on 30 January 2018, a further fundraising of at least £0.68m ($0.96m) (before expenses) through the issue of at least 5,463,011 new ordinary shares of £0.01 each in the Company ("New Ordinary Shares") at an issue price of 12.5 pence per New Ordinary Share (the "Issue Price"), being a discount of 9.1 per cent to the closing mid-price on 1 February 2018.

 

The fundraising comprises a firm institutional placing (the "Placing") by Brandon Hill Capital Limited and Beaufort Securities Limited, as joint brokers to the Company, a further subscription to invest in the Company (the "Subscription"), as well as a retail investor offer via PrimaryBid (the "Offer") (together the "Fundraising").

 

Each new Ordinary Share issued in connection with the Fundraising will be issued with a warrant which is convertible into one new Ordinary Share. The warrants will be exercisable at the request of the holder at any time in the 2 years following issue (being the date of Admission) with an exercise price of 20p each.

 

Firm Placing

 

The Company has raised £0.6m ($0.85m) (before expenses) via a placing by Brandon Hill Capital Limited and Beaufort Securities Limited, through the issue of 4,840,600 New Ordinary Shares (the "Placing Shares") at the Issue Price.

 

Application will be made for admission to trading on AIM of the Placing Shares and dealings in the Placing Shares are expected to start on 8 February 2018.

 

 

Subscription

 

The Company has received a further subscription for £0.078m ($0.11m) from private investors through the issue of 622,411 New Ordinary Shares (the "Subscription Shares") at the Issue Price.

 

Application will be made for admission to trading on AIM (conditional upon receipt of the relevant subscription proceeds) for 80,000 of the Subscription Shares which are expected to be admitted to trading on AIM on 28 February 2018 and 542,411 of the Subscription Shares which are expected to be admitted to trading on AIM on 30 March 2018.

 

The Placing Shares and Subscription Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

 

Offer

 

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the Fundraising by applying exclusively through the PrimaryBid.com platform. PrimaryBid does not charge investors any commission for this service.

 

The Offer, via the PrimaryBid.com platform, will be open to individual and institutional investors from 4.30 p.m. on 2 February 2018 to 5 p.m. on 4 February 2018. The Offer may close early at the Company's discretion.

 

The Company is seeking to raise further funds via the issue of New Ordinary Shares (the "Offer Shares") at an issue price of 12.5 pence (representing a discount of 9.1 per cent to the closing mid-price per Ordinary Share on 1 February 2018).

 

Subscriptions under the Offer will be considered by the Company on a "first come, first served" basis, subject to conditions (which are available to view on PrimaryBid.com) with any investment request over £100,000 first requiring consultation with the Company.

 

No commission is charged to investors on applications to participate in the Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

 

For further information on PrimaryBid.com or the procedure for applications under the Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 (0)20 7491 6519. 

 

A further announcement will be made by the Company on 5 February 2018 in relation to the Offer.

 

Application will be made for admission to trading on AIM of the Offer Shares in due course and dealings in these New Ordinary Shares are expected to start on 8 February 2018.

 

The Offer Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

 

 

 

 

Use of Funds

 

The funds will be used for further supplier pre-payments, capital expenditure in Mozambique and general working capital purposes as set out in the announcement of 30 January 2018.

 

Investor Presentation

 

The investor presentation for the Fundraising is available on the company's website. Any materials or information set out on the Company website have not been approved for the purposes of section 21 of the Financial Services and Markets Act 2000 by PrimaryBid Ltd and are the responsibility of Obtala Ltd.

 

 

 

Obtala Limited

Miles Pelham - Chairman

Paul Dolan - CEO

Martin Collins - Deputy Chairman

www.obtala.com

 

+44 (0)20 7099 1940

Northland Capital Partners Ltd (Nomad and Joint Broker)

Tom Price

David Hignell

 

+44 (0)20 3861 6625

Brandon Hill Capital (Joint Broker)

Jonathan Evans

 

Beaufort Securities Limited (Joint Broker)

Jon Belliss

+44 (0)20 3463 5000

 

 

+44 (0)20 7382 8300

PrimaryBid Limited

Dave Mutton

+44 (0)20 7491 6519

 

 

 

Details of the Offer

 

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Fundraising. The Company is therefore making the Offer exclusively through PrimaryBid.com.

 

Retail and other investors may participate in the Offer of New Ordinary Shares on a first come, first served basis, exclusively through PrimaryBid.com.

 

The Company is raising further funds via the Offer, through the issue of New Ordinary Shares at the Issue Price, payable in full on acceptance.

 

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

 

There is a minimum subscription of £1,000 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com. This allocation will be filled on a "first come first served" basis.

 

Any investment request in excess of £100,000 will require the Company's consent and may be subject to scale back.

 

For further details please refer to the PrimaryBid.com website at www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

 

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

 

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBRGDDXGGBGID
Date   Source Headline
21st Nov 20257:00 amRNSCancellation - Woodbois Limited
4th Nov 202511:48 amRNSDirectorate change
20th Oct 20252:05 pmRNSChange of Adviser
26th Aug 20256:00 pmRNSSuspended Companies Notice - Deletion
22nd Jul 20254:25 pmRNSResignation of Director
1st Jul 20257:30 amRNSSuspension - Woodbois Limited
5th Jun 20257:00 amRNSTrading Update and delay re. Annual Report
30th May 20255:00 pmRNSTotal Voting Rights
16th May 20252:18 pmRNSUpdate on Subscription Options, BGFI Bank & TVR
14th May 20255:25 pmRNSResignation of Director
30th Apr 20255:00 pmRNSTotal Voting Rights
30th Apr 20254:09 pmRNSResult of AGM
22nd Apr 202512:38 pmRNSResult of General Meeting and Total Voting Rights
2nd Apr 20253:05 pmRNSPosting of Circular and Notice of GM and AGM
28th Mar 20258:00 amRNSResult of Subscription
28th Mar 20257:00 amRNSProposed fundraising and other matters
25th Mar 20257:00 amRNSBoard Changes
5th Feb 202510:30 amRNSBusiness Update
17th Jan 20252:00 pmRNSUpdate re. facilities with Nykredit Bank
10th Jan 20257:54 amRNSTermination of Facilities with Nykredit Bank
9th Jan 20253:40 pmRNSAppointment of CEO
6th Jan 20259:46 amRNSUpdate re directorate
6th Jan 20257:00 amRNSHolding(s) in Company
31st Dec 20241:30 pmRNSTotal Voting Rights
24th Dec 20241:02 pmRNSResignation of executive directors
19th Dec 20247:00 amRNSConversion of non-voting shares
9th Dec 20247:00 amRNSMarket Update
29th Nov 20245:00 pmRNSTotal voting rights
20th Nov 20244:35 pmRNSUpdate re. fundraising
19th Nov 20247:00 amRNSSubscription to raise £1 million
11th Nov 20247:30 amRNSRestoration - Woodbois Limited
11th Nov 20247:00 amRNSAppointment of nominated adviser and other matters
22nd Oct 20249:47 amRNSMarket Update
18th Oct 20244:01 pmRNSUpdate on Fundraising with AXIS &Corporate Matters
9th Oct 20242:59 pmRNSTermination of Director
9th Oct 202411:20 amRNSSuspension - Woodbois Limited
9th Oct 202411:20 amRNSResignation of Nominated Adviser and Suspension
4th Oct 20247:00 amRNSSubscription of £1 million
30th Sep 20247:00 amRNSHalf Year Results
25th Sep 20242:41 pmRNSHolding(s) in Company
18th Sep 20245:04 pmRNSGabon Wood Sector Operational Update
13th Sep 20244:45 pmRNSHolding(s) in Company
10th Sep 20247:01 amRNSHolding(s) in Company
10th Sep 20247:00 amRNSCorporate Update and Strategic Developments
2nd Sep 20247:00 amRNSHolding(s) in Company
22nd Aug 20244:00 pmRNSHolding(s) in Company
21st Aug 202411:36 amRNSHolding(s) in Company
21st Aug 202411:27 amRNSHolding(s) in Company
12th Aug 20249:48 amRNSDirectorate Change
28th Jun 20247:00 amRNSAudited results for FY 2023

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.